Drug profile · INN
clorazepate dipotassium
CLORAZEPATE DIPOTASSIUM
clorazepate dipotassium (CLORAZEPATE DIPOTASSIUM) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Quantum Biopharma. Route of administration: oral. Current US regulatory status: approved.
Drug details — clorazepate dipotassium
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 14
- Programs
- 0
- Data quality
- 0.89
Quick answer
clorazepate dipotassium (CLORAZEPATE DIPOTASSIUM) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Quantum Biopharma. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
GABA-A receptor; anion channel positive allosteric modulator
Primary target: GABA-A receptor; anion channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
-
US 12377151
Immobilized endoglycosidase fusion protein and use thereof
granted -
US 12370266
Polymer composite nanomaterial encapsulation system
granted -
US 12312377
Biconjugatable labels and methods of use
granted -
US 12195454
Compounds for imaging tau proteins that accumulate in the brain
granted -
US 12102694
Radiolabeled compound producing method and producing apparatus, radiolabeled compound and radioisotope producing apparatus
granted -
US 11834688
Ligase fusion proteins and application thereof
granted -
US 11826432
Linkers, conjugates and applications thereof
granted -
US 11667628
Compounds for imaging tau proteins that accumulate in brain
granted -
US 11453870
Ligase fusion proteins and application thereof
granted -
US 11389550
Nanoparticle, contrast agent for magnetic resonance imaging containing same, and ligand compound
granted -
US 11345658
Compounds and compositions comprising the same for treating hypertension or heart failure
granted -
US 11020479
Method for production of solid water particles for homeopathy
granted -
US 10604516
Compounds for imaging tau proteins that accumulate in the brain
granted -
US 8646246
Method of preparing a composition in blister packages
granted
Frequently asked questions
What is clorazepate dipotassium?
clorazepate dipotassium (CLORAZEPATE DIPOTASSIUM) is a gaba-a receptor; anion channel positive allosteric modulator. Associated with Quantum Biopharma. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for clorazepate dipotassium?
CLORAZEPATE DIPOTASSIUM is a marketed brand name for clorazepate dipotassium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of clorazepate dipotassium?
clorazepate dipotassium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.